[Neuro-Behçet's disease]

Ryoikibetsu Shokogun Shirizu. 2003:(40):364-8.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antidepressive Agents / therapeutic use
  • Antipsychotic Agents / therapeutic use
  • Behcet Syndrome* / classification
  • Behcet Syndrome* / complications
  • Behcet Syndrome* / diagnosis
  • Behcet Syndrome* / drug therapy
  • Cytokines
  • HLA-B Antigens
  • HLA-B51 Antigen
  • Heat-Shock Proteins
  • Humans
  • Mental Disorders* / diagnosis
  • Mental Disorders* / drug therapy
  • Mental Disorders* / etiology
  • Methotrexate / administration & dosage
  • Methylprednisolone / administration & dosage
  • Nervous System Diseases* / diagnosis
  • Nervous System Diseases* / drug therapy
  • Nervous System Diseases* / etiology
  • Neutrophil Activation
  • Prognosis
  • Pulse Therapy, Drug

Substances

  • Antidepressive Agents
  • Antipsychotic Agents
  • Cytokines
  • HLA-B Antigens
  • HLA-B51 Antigen
  • Heat-Shock Proteins
  • Methylprednisolone
  • Methotrexate